Tags

Type your tag names separated by a space and hit enter

No. 262-Prenatal Screening for and Diagnosis of Aneuploidy in Twin Pregnancies.
J Obstet Gynaecol Can. 2017 Sep; 39(9):e347-e361.JO

Abstract

OBJECTIVE

To provide a Canadian consensus document with recommendations on prenatal screening for and diagnosis of fetal aneuploidy (e.g., Down syndrome and trisomy 18) in twin pregnancies.

OPTIONS

The process of prenatal screening and diagnosis in twin pregnancies is complex. This document reviews the options available to pregnant women and the challenges specific to screening and diagnosis in a twin pregnancy.

OUTCOMES

Clinicians will be better informed about the accuracy of different screening options in twin pregnancies and about techniques of invasive prenatal diagnosis in twins.

EVIDENCE

PubMed and Cochrane Database were searched for relevant English and French language articles published between 1985 and 2010, using appropriate controlled vocabulary and key words (aneuploidy, Down syndrome, trisomy, prenatal screening, genetic health risk, genetic health surveillance, prenatal diagnosis, twin gestation). Results were restricted to systematic reviews, randomized controlled trials, and relevant observational studies. Searches were updated on a regular basis and incorporated in the guideline to August 2010. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology assessment-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. The previous Society of Obstetricians and Gynaecologists of Canada guidelines regarding prenatal screening were also reviewed in developing this clinical practice guideline.

VALUES

The quality of evidence was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table 1).

BENEFITS, HARMS, AND COSTS

There is a need for specific guidelines for prenatal screening and diagnosis in twins. These guidelines should assist health care providers in the approach to this aspect of prenatal care of women with twin pregnancies.

SUMMARY STATEMENTS

RECOMMENDATIONS.

Authors+Show Affiliations

Montreal, QC.Vancouver, BC.

Pub Type(s)

Journal Article
Practice Guideline

Language

eng

PubMed ID

28859779

Citation

Audibert, François, and Alain Gagnon. "No. 262-Prenatal Screening for and Diagnosis of Aneuploidy in Twin Pregnancies." Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstetrique Et Gynecologie Du Canada : JOGC, vol. 39, no. 9, 2017, pp. e347-e361.
Audibert F, Gagnon A. No. 262-Prenatal Screening for and Diagnosis of Aneuploidy in Twin Pregnancies. J Obstet Gynaecol Can. 2017;39(9):e347-e361.
Audibert, F., & Gagnon, A. (2017). No. 262-Prenatal Screening for and Diagnosis of Aneuploidy in Twin Pregnancies. Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstetrique Et Gynecologie Du Canada : JOGC, 39(9), e347-e361. https://doi.org/10.1016/j.jogc.2017.06.015
Audibert F, Gagnon A. No. 262-Prenatal Screening for and Diagnosis of Aneuploidy in Twin Pregnancies. J Obstet Gynaecol Can. 2017;39(9):e347-e361. PubMed PMID: 28859779.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - No. 262-Prenatal Screening for and Diagnosis of Aneuploidy in Twin Pregnancies. AU - Audibert,François, AU - Gagnon,Alain, PY - 2017/9/2/entrez PY - 2017/9/2/pubmed PY - 2019/7/18/medline KW - Prenatal screening KW - amniocentesis KW - chorionic villus sampling KW - maternal serum screening KW - nuchal translucency KW - prenatal diagnosis KW - twin pregnancy SP - e347 EP - e361 JF - Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC JO - J Obstet Gynaecol Can VL - 39 IS - 9 N2 - OBJECTIVE: To provide a Canadian consensus document with recommendations on prenatal screening for and diagnosis of fetal aneuploidy (e.g., Down syndrome and trisomy 18) in twin pregnancies. OPTIONS: The process of prenatal screening and diagnosis in twin pregnancies is complex. This document reviews the options available to pregnant women and the challenges specific to screening and diagnosis in a twin pregnancy. OUTCOMES: Clinicians will be better informed about the accuracy of different screening options in twin pregnancies and about techniques of invasive prenatal diagnosis in twins. EVIDENCE: PubMed and Cochrane Database were searched for relevant English and French language articles published between 1985 and 2010, using appropriate controlled vocabulary and key words (aneuploidy, Down syndrome, trisomy, prenatal screening, genetic health risk, genetic health surveillance, prenatal diagnosis, twin gestation). Results were restricted to systematic reviews, randomized controlled trials, and relevant observational studies. Searches were updated on a regular basis and incorporated in the guideline to August 2010. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology assessment-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. The previous Society of Obstetricians and Gynaecologists of Canada guidelines regarding prenatal screening were also reviewed in developing this clinical practice guideline. VALUES: The quality of evidence was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table 1). BENEFITS, HARMS, AND COSTS: There is a need for specific guidelines for prenatal screening and diagnosis in twins. These guidelines should assist health care providers in the approach to this aspect of prenatal care of women with twin pregnancies. SUMMARY STATEMENTS: RECOMMENDATIONS. SN - 1701-2163 UR - https://www.unboundmedicine.com/medline/citation/28859779/No__262_Prenatal_Screening_for_and_Diagnosis_of_Aneuploidy_in_Twin_Pregnancies_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1701-2163(17)30608-4 DB - PRIME DP - Unbound Medicine ER -